Sordilla, Alma A.
HRN: 24-98-72 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/14/2024
METRONIDAZOLE 500MG (TAB)
05/14/2024
05/21/2024
PO
1 Tablet
TID
S/P PLTCS With BTL
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes